Dimensional Fund Advisors LP Has $108.43 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Dimensional Fund Advisors LP decreased its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 1.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 182,408 shares of the biotechnology company's stock after selling 1,770 shares during the quarter. Dimensional Fund Advisors LP owned about 0.24% of Axon Enterprise worth $108,425,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Asset Dedication LLC boosted its position in shares of Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC lifted its stake in Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock valued at $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after buying an additional 21 shares in the last quarter. Burns Matteson Capital Management LLC grew its position in Axon Enterprise by 3.4% in the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company's stock worth $450,000 after buying an additional 25 shares during the last quarter. Finally, Transcend Capital Advisors LLC increased its holdings in shares of Axon Enterprise by 3.6% in the fourth quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company's stock valued at $431,000 after buying an additional 25 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Up 1.9 %

NASDAQ AXON traded up $11.69 during trading on Thursday, reaching $624.99. The company's stock had a trading volume of 296,403 shares, compared to its average volume of 759,445. The stock has a market capitalization of $48.65 billion, a PE ratio of 161.50, a PEG ratio of 5.17 and a beta of 1.13. The business has a 50-day moving average price of $549.12 and a 200-day moving average price of $574.38. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent research reports. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price on the stock. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Needham & Company LLC reaffirmed a "buy" rating and issued a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, April 23rd. Finally, Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $626.45.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.